Water and Salt Retention in CAPD Patients Treated with Minoxidil

Lowenthal D.T. , Onesti O. , Mutterperl R. Long-term clinical effects, bioavailability and kinetics of Minoxidil in relation to renal function. J Clin Pharmacol 1978; 2: 500–508.

Plouin P.F. , Vital Morgado A. , AlhencOelas F. Hypertension arterielle rebelle: Effets du Minoxidil sur la pression arterielle et le volume plasmatique. Press Med 19791; 8: 3135–3138.

Baer L. , Radichevich I. , Williams O.S. Treatment of drug-resistant hypertension with Minoxidil or angiotensinconverting enzyme inhibitor: Blood pressure, renin, aldosterone and electrolytes responses. J Cardiovasc Pharmacol 1980; 2: 8206–8216.

Keusch Ow , Weidmann P. , Campese V.M. Minoxidil therapy in refractory hypertension: Analysis of 155 patients. Nephron 1978; 21: 1–15.

Campese V.M. Minoxidil: A review of its pharmacological properties and therapeutic use. Drugs 1981; 22: 257–278.

Nolph K.D. , Miller F.N. , Pyle W.K. An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis. Kidney Int 1981; 20: 543–548.

Verger C. , Larpent L. , Dumontet M. Prognostic value of peritoneal equilibration curves in CAPD patients. In: Proceedings of the Third International Symposium on Peritoneal Dialysis (Washington, DC, 1984). In press.